PIK3CD-AS2: A Potential Drug Target and Biomarker for Prostate Cancer

Target Name: PIK3CD-AS2

NCBI ID: G101929074

PIK3CD-AS2

Other Name(s): PIK3CD antisense RNA 2, transcript variant 1 | PIK3CD-AS2 variant 1 | PIK3CD antisense RNA 2

PIK3CD-AS2: A Potential Drug Target and Biomarker for Prostate Cancer

Prostate cancer is a leading cause of cancer-related deaths worldwide, with an estimated 1,200,000 new cases and 600,000 deaths in the United States alone in 2020. The androgen-sensitive prostate cancer (ASPC) represents the most common form of the disease and is often treated with androgens, such as testosterone, to control the growth of the cancer. However, androgens can promote the growth and spread of the disease, making them a difficult treatment option for many patients.

The PIK3CD gene is a key regulator of androgen signaling in prostate cancer. The PIK3CD gene encodes a protein that plays a critical role in the development and maintenance of androgenic stem cells (ASCs), which are a vital source of androgens for the cancer. In addition, the PIK3CD gene has also been implicated in the development of androgen-sensitive prostate cancer (ASPC).

PIK3CD-AS2: A Potential Drug Target

The PIK3CD gene has been a focus of interest in the development of new drug targets for ASPC because of its role in the disease. Several studies have identified potential drug targets based on the PIK3CD gene, including the potential targets PIK3CD-AS1, PIK3CD-AS2, and PIK3CD-AS3.

PIK3CD-AS2 is a potential drug target for ASPC because it is a known gene expression regulator associated with the development of ASPC. The PIK3CD-AS2 gene has been shown to be highly expressed in ASCs and has been associated with the development of ASPC. In addition, several studies have shown that inhibiting the PIK3CD-AS2 gene has anti-aspartic acid (ASP) content in ASCs and can reduce the growth and spread of ASPC.

The PIK3CD-AS2 gene has also been shown to be involved in the regulation of key signaling pathways, including the androgen signaling pathway. Several studies have shown that the PIK3CD-AS2 gene is involved in the regulation of androgen receptor (AR) signaling, which is critical for the development and maintenance of androgens in ASCs. In addition, the PIK3CD-AS2 gene has also been shown to be involved in the regulation of the androgen-induced apoptosis pathway, which is important for the control of androgen-induced cell death.

The potential drug target for PIK3CD-AS2 is the inhibition of AR signaling, which can be achieved through various means, such as inhibition of AR transcriptional activity, inhibition of AR-mediated signaling pathways, or inhibition of AR-mediated downstream signaling pathways. These approaches have been shown to be effective in the treatment of ASPC.

PIK3CD-AS2: A Potential Biomarker

In addition to its potential as a drug target, PIK3CD-AS2 is also a potential biomarker for ASPC. The PIK3CD-AS2 gene has been shown to be involved in the regulation of key signaling pathways associated with the development and progression of ASPC.

Several studies have shown that the expression of the PIK3CD-AS2 gene is significantly increased in ASCs compared to non-ASCs. In addition, the PIK3CD-AS2 gene has also been shown to be involved in the regulation of key signaling pathways associated with the development and progression of ASPC, including the androgen signaling pathway.

The androgen signaling pathway is a critical pathway involved in the development and maintenance of androgens in ASCs, including testosterone. Several studies have shown that the PIK3CD-AS2 gene is involved in the regulation of androgen receptor (AR) signaling, which is critical for the development and maintenance of androgens in ASCs. In addition, the PIK3CD-AS2 gene has also been shown to be involved in the regulation of androgen-induced apoptosis pathway, which is important for the control of androgen-induced cell death.

The potential biomarker for

Protein Name: PIK3CD Antisense RNA 2

The "PIK3CD-AS2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PIK3CD-AS2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets